| Literature DB >> 22152339 |
Toshiyuki Tainaka1,2, Yasuhito Shimada1,3,4,5, Junya Kuroyanagi1, Liqing Zang1,6, Takehiko Oka1, Yuhei Nishimura1,3,4,5, Norihiro Nishimura6, Toshio Tanaka1,3,4,5.
Abstract
BACKGROUND: High dietary intake of vegetable products is beneficial against obesity and its related diseases such as dyslipidemia, nonalcoholic fatty liver disease, and cancer. We previously developed a diet-induced obesity model of zebrafish (DIO-zebrafish) that develops visceral adiposity, dyslipidemia, and liver steatosis. Zebrafish is a polyphagous animal; thus we hypothesized that DIO-zebrafish could be used for transcriptome analysis of anti-obesity effects of vegetables.Entities:
Year: 2011 PMID: 22152339 PMCID: PMC3275548 DOI: 10.1186/1743-7075-8-88
Source DB: PubMed Journal: Nutr Metab (Lond) ISSN: 1743-7075 Impact factor: 4.169
Figure 1Assessment of body weight, plasma TG, and hepatic steatosis in zebrafish overfed with Campari and regular tomatoes. (A) Feeding condition of each group. Group 1, normal feeding; group 2, overfeeding of Artemia with Tetramin (vehicle); group 3, overfeeding with regular tomato; group 4, overfeeding with Campari tomato. Feeding experiments were conducted over 2 and 4 weeks. (B) Average body weight in each group during 4-week feeding experiments. Values are mean ± SD. Each group contained 20 samples. **P < 0.05; ***P < 0.01 vs. vehicle with overfeeding, black circles. (C) Change of plasma TG levels in the each group. ***P < 0.01 vs. vehicle with overfeeding, black circles. (D) Feeding behaviour assay counting Artemia numbers 90 min after feeding at 2 weeks. No significant difference was observed among vehicle, regular tomato, and Campari tomato administration in overfeeding groups. (E) Oil red O staining of liver sections. Campari tomato reduced the number and size of lipid droplets (red) compared with overfeeding and overfeeding regular tomato. (F and G) qPCR-assessed gene expression in the livers of DIO and normally fed zebrafish. Expression of ppar-ab (F) and ppargc1-like (G), a zebrafish homolog of human PPAR-α and PPARGC1 (PGC-1α, was normalized to actb expression. Values are mean ± SE (n = 5/group). *P < 0.05 vs. vehicle with overfeeding (OF).
Carotenoids, sugar contents, ascorbic acid, and NO3- determination in Campari and regular tomato
| Lycopene (mg/100 g) | β-carotene (mg/100 g) | Brix (%) | Ascorbic acid (mg/100 g) | NO3- (mg/Kg) | |
|---|---|---|---|---|---|
| Regular tomato | 1.48 ± 0.28 | 0.48 ± 0.09 | 5.10 ± 0.61 | 17.28 ± 2.59 | 32.04 ± 18.45 |
| Campari tomato | 3.22 ± 0.85 * | 1.06 ± 0.21 * | 8.08 ± 0.15 * | 20.90 ± 4.23 | 7.30 ± 2.93 ** |
* P < 0.05; ** P < 0.01
Figure 2Lycopene effects on body weight, plasma TG, and hepatic steatosis in DIO-zebrafish. (A) Average body weight in each group during 4-week feeding experiments. Values are mean ± SD. Each group contained 20 samples. *P < 0.05; **P < 0.01 vs. vehicle with overfeeding, black circles. (B) Change of plasma TG levels in each group. *P < 0.05 vs. vehicle with overfeeding. (C) Oil red O staining of liver sections.
QPCR of genes from biological networks in Campari tomato treatment compared with regular strain
| gene | QPCR | Microarray data |
|---|---|---|
| aldoca | 1.38 ± 0.46 * | 2.23 ** |
| foxo1 | 2.42 ± 0.59 ** | n.d. |
| ldlr | 1.53 ± 0.31 * | 1.95 ** |
| nr2f2 | 2.34 ± 0.53 ** | 2.85 ** |
| pde4ba | 0.13 ± 0.35 ** | 0.06 ** |
| rarga | 0.10 ± 0.22 ** | 0.06 ** |
| srebf1 | 0.49 ± 0.18 * | n.d. |
| srebf2 | 1.31 ± 0.52 * | 2.32 ** |
n = 4, * P < 0.05; ** P < 0.01
Ontology analysis of genes with altered expression in the Campari tomato-fed fish relative to regular strain tomato-fed fish
| Group | GO ID | GO Terms | Genes | |
|---|---|---|---|---|
| Lipid | GO:0006629 | lipid metabolic process | ldlr stat5b cel hadha mgll nr2f2 srebf2 | 0.0757 |
| GO:0008289 | lipid binding | gas1 pebp1 ncf1 hadha rassf1 rtn4rl1 | 0.0468 | |
| GO:0008202 | steroid metabolic process | ldlr stat5b cel srebf2 | 0.0468 | |
| GO:0005543 | phospholipid binding | gas1 pebp1 ncf1 rtn4rl1 | 0.0795 | |
| GO:0016125 | sterol metabplic process | ldlr cel srebf2 | 0.0468 | |
| GO:0008203 | choresterol metabolic process | ldlr cel srebf2 | 0.0407 | |
| Carbohydrate | GO:0008643 | carbohydrate transport | yes1 slc2a8 slc2a12 | 0.0468 |
| GO:0015758 | glucose transport | yes1 slc2a8 | 0.0468 | |
| Other | GO:0022892 | substrate-specific transporter activity | hbd tomm7 ankh slc2a8 slc2a12 ldlr accn4 hbz cacnb1 slc1a1 | 0.0774 |
| GO:0031090 | organelle membrane | mtx1 oxa1l dhodh nup37 tomm7 slc2a8 hadha srebf2 nupl2 | 0.0809 | |
| GO:0007049 | cell cycle | gas1 stat5b btg3 chfr kifc1 mapre3 rassf1 | 0.0566 | |
| GO:0033036 | macromolecule localization | mtx1 oxa1l vangl2 nup37 ppp1r10 tomm7 nupl2 | 0.0865 | |
Top networks from pathway analysis of Campari tomato vs. regular tomato
| ID | Associated Network Functions | Score |
|---|---|---|
| 1 | Gene Expression, Lipid Metabolism, Small Molecule Biochemistry | 47 |
| 2 | Endocrine System Disorders, Metabolic Disease, Gene Expression | 25 |
| 3 | Cancer, Hematological System Development and Function, Cell Cycle | 19 |
Figure 3Pathway analysis of liver from Campari tomato treatment. Biological networks identified by IPA using 90 human orthologs altered in Campari tomato treatment. Intensity of node color indicates magnitude of upregulation (red) and downregulation (green). (A) Network 1, related to lipid metabolism. (B) Network 2, also related to lipid metabolism. (C) Network 3, related to cancer compromise. The scores of these networks are described in Table 2. Solid arrow, induction and/or activation; solid line without arrow head, binding; dashed arrow, suppression and/or inhibition.